Drug intelligence / Profile preview

Estraderm MX

Development stage
Unknown
Lead developer
Novartis
Administration
Transdermal
01

Overview

**Estraderm MX** is a transdermal patch formulation of estradiol, a bioidentical form of the female hormone estrogen, designed for hormone replacement therapy (HRT) in postmenopausal women. It delivers estradiol continuously through the skin at controlled rates (e.g., 50 or 100 micrograms/day) for up to 4 days per patch, bypassing first-pass liver metabolism to mimic natural estrogen levels. Primarily indicated for relieving menopausal symptoms such as hot flushes, night sweats, vaginal dryness, and osteoporosis prevention in high-risk postmenopausal women intolerant to other therapies, it requires progestagen supplementation in women with an intact uterus to mitigate endometrial hyperplasia risk. Manufactured as a square, transparent, self-adhesive patch with an impermeable polyester backing and adhesive matrix containing estradiol hemihydrate.

Brand names
Estraderm MX
Other names
Estraderm MX 50Estraderm MX 100
02

Targets

ESR2 (ERβ)GPER1 (G protein-coupled estrogen receptor 1)ESR1 (ERα)

Beyond the preview

Go deeper on Estraderm MX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Estraderm MX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call